- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00570115
Left Atrial Volume and Function Evaluation in Patients With Obstructive Sleep Apnea
May 7, 2012 updated by: Associação Fundo de Incentivo à Pesquisa
Left Atrial Volume and Function in Patients With Obstructive Sleep Apnea Assessed by Real Time Three Dimensional Echocardiography
The purpose of this study is to determine whether patients with obstructive sleep apnea have any changes in left atrial morphology and function evaluated by echocardiography three dimensional
Study Overview
Status
Completed
Conditions
Detailed Description
Several studies have been suggesting that Obstructive Sleep Apnea contributes to deterioration of left ventricular diastolic function .
It may lead to atrial myocardium stretching and enlargement which may be associated to increased risk of cardiovascular events.
We hypothesized that morphological and functional LA changes might be found using three dimensional echo, and that such alterations are related to obstructive sleep apnea presence.
Study Type
Observational
Enrollment (Actual)
106
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil, 04020060
- Instituto do Sono/Federal University of Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The investigators recruited 56 recently diagnosed OSA patients, confirmed by full polysomnography (PSG), referred to Sleep Laboratory of Psychobiology Department of Federal University of Sao Paulo, Brazil, according to the following inclusion criteria: both genders aging from 29 to 70 years old, with apnea-hypopnea index (AHI) >5 events/hour of sleep.
Control group comprised 50 healthy community subjects without OSA confirmed by full PSG, matched by age, gender, and BMI.
Description
Inclusion Criteria:
- Age from 30 to 70
- Apnea-hypopnea index > 5 by polysomnography
Exclusion Criteria:
- Any cardiac disease
- Poor imaging quality by mean of echocardiography
- non-sinusal Rhythm
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
A
The subjects for this group are matched for age, gender, body mass index.
The presence of obstructive sleep apnea will divide the cohort in 02 subgroups: non-Obstructive Sleep Apnea and Obstructive Sleep Apnea
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Left Atrial enlargement
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Sergio Tufik, PhD,MD., Federal University of São Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2007
Study Completion (Actual)
November 1, 2007
Study Registration Dates
First Submitted
December 7, 2007
First Submitted That Met QC Criteria
December 7, 2007
First Posted (Estimate)
December 10, 2007
Study Record Updates
Last Update Posted (Estimate)
May 8, 2012
Last Update Submitted That Met QC Criteria
May 7, 2012
Last Verified
December 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ecoera-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea Syndromes
-
Tampere University HospitalActive, not recruiting
-
Sheffield Children's NHS Foundation TrustCompletedSleep Apnea Syndromes in ChildrenUnited Kingdom
-
University Hospital, AngersCompletedCancer | Sleep Apnea Syndromes, ObstructiveFrance
-
University Hospital, GrenobleIcadom; DOCAPOST; SunriseCompletedSleep Apnea Syndrome, ObstructiveFrance
-
ResMedCRI-The Clinical Research Institute GmbH; University Hospital RegensburgCompletedObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaSwitzerland, Spain, Denmark, Portugal, France, Germany
-
Hillel Yaffe Medical CenterUnknownSleep Apnea Syndromes, ObstructiveIsrael
-
Democritus University of ThraceRecruitingConcentration Ability Impaired | Sleep Apnea Syndrome, Obstructive | Blinking | Pupil Diameter | DrowsinessGreece
-
Poitiers University HospitalCompletedObstructive Sleep Apnea Syndromes
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States